CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Cough syrup for adults and children +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02486835
NCT02486835N/ACompleted

Efficacy & Tolerability of a Specific Plantain,Thyme and Honey Cough Syrup vs Placebo in Child Cough Due to Common Cold

Clalit Health Services·interventional·Posted Jul 1, 2015·Updated Jan 29, 2018

In Brief

A clinical study evaluating Cough syrup for adults and children and Placebo for Cough. Completed, enrolled 150 participants across 4 sites.

Detailed Summary

Cough is a life saving reflex, therefore it is important, especially in pediatrics, to calm cough spells without sedating the reflex. The intent of this study is to use a protective syrup with does not act as a sedative or as a potent mucolytic and measure its efficacy and safety versus placebo in children with moderate to severe night and daily cough. Cough is assessed with a validated parent questionnaire. The degree of disturbance of cough is followed immediately after one night administration of the study products and daily for 4 nights, 3 days.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCough
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 1, 2015
Enrollment StartDec 23, 2015
Primary CompletionApr 3, 2016
Study CompletionApr 6, 2016
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11.0 years ago

Interventions

Cough syrup for adults and childrendevice

Dosage is 5 ml three times a day for 4 nights, 3 days

Placebodevice

Dosage is 5 ml three times a day for 4 nights, 3 days